ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oligonucleotides Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-32Y361
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oligonucleotides Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Oligonucleotides Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-32Y361
Report
July 2025
Pages:151
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems

Oligonucleotides Market Size

In 2024, the global market size of Oligonucleotides was estimated to be worth US$ 1518 million and is forecast to reach approximately US$ 2950 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.

Oligonucleotides Market

Oligonucleotides Market

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oligonucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotides.
The Oligonucleotides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Oligonucleotides Market Report

Report Metric Details
Report Name Oligonucleotides Market
CAGR 10.1%
Segment by Type
  • DNA Oligos
  • RNA Oligos
Segment by Application
  • Pharmaceutical
  • Research
  • Diagnostic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, GenScript, BBI Life Sciences, GeneDesign, TriLink BioTechnologies, SGS DNA, LC Sciences, Twist Bioscience, Creative Biogene, General Biosystems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Oligonucleotides in global and regional level.
  • Chapter 3: Detailed analysis of Oligonucleotides company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligonucleotides revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the market share of major companies in Oligonucleotides Market?

Ans: Global top five manufacturers hold a share over 45%.

What is the Oligonucleotides Market share by type?

Ans: In terms of product, DNA Oligos is the largest segment, with a share over 65%.

Who are the main players in the Oligonucleotides Market report?

Ans: The main players in the Oligonucleotides Market are Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, Eurogentec S.A, Nitto Denko Avecia Inc, GenScript, BBI Life Sciences, GeneDesign, TriLink BioTechnologies, SGS DNA, LC Sciences, Twist Bioscience, Creative Biogene, General Biosystems

What are the Application segmentation covered in the Oligonucleotides Market report?

Ans: The Applications covered in the Oligonucleotides Market report are Pharmaceutical, Research, Diagnostic

What are the Type segmentation covered in the Oligonucleotides Market report?

Ans: The Types covered in the Oligonucleotides Market report are DNA Oligos, RNA Oligos

1 Study Coverage
1.1 Oligonucleotides Product Introduction
1.2 Market by Type
1.2.1 Global Oligonucleotides Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 DNA Oligos
1.2.3 RNA Oligos
1.3 Market by Application
1.3.1 Global Oligonucleotides Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Pharmaceutical
1.3.3 Research
1.3.4 Diagnostic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oligonucleotides Market Size Estimates and Forecasts
2.2 Oligonucleotides Market Size by Region: 2024 Versus 2031
2.2.1 Global Oligonucleotides Revenue by Region: 2020-2025
2.2.2 Global Oligonucleotides Revenue Forecast by Region (2026-2031)
2.2.3 Global Oligonucleotides Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Oligonucleotides Revenue by Type (2020-2031)
3.1.2 Global Oligonucleotides Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Oligonucleotides Revenue by Application (2020-2031)
3.2.2 Global Oligonucleotides Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 DNA Oligos of Oligonucleotides Revenue Market Share by Application
3.3.2 RNA Oligos of Oligonucleotides Revenue Market Share by Application
4 Global Oligonucleotides by Company
4.1 Global Oligonucleotides Revenue by Company (2020-2025)
4.2 Global Oligonucleotides Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Oligonucleotides Companies around the World: Ranking by Revenue
4.3.2 Global Oligonucleotides Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Oligonucleotides Companies Headquarters & Product Type
4.4.1 Global Oligonucleotides Companies Headquarters
4.4.2 Date of International Companies Enter into Oligonucleotides Market
4.4.3 Global Oligonucleotides Companies Product & Service
4.4.4 DNA Oligos Revenue Market Share of Oligonucleotides by Company
4.4.5 RNA Oligos Revenue Market Share of Oligonucleotides by Company
4.5 Global Oligonucleotides Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Integrated DNA Technologies
5.1.1 Integrated DNA Technologies Corporation Information
5.1.2 Integrated DNA Technologies Description, Business Overview
5.1.3 Integrated DNA Technologies Oligonucleotides Products Offered
5.1.4 Integrated DNA Technologies Oligonucleotides Revenue and Gross Margin (2020-2025)
5.1.5 Integrated DNA Technologies Oligonucleotides Revenue by Product in 2024
5.1.6 Integrated DNA Technologies Oligonucleotides Revenue by Application in 2024
5.1.7 Integrated DNA Technologies Oligonucleotides Revenue by Geographic Area in 2024
5.1.8 Integrated DNA Technologies Recent Developments
5.2 Agilent
5.2.1 Agilent Corporation Information
5.2.2 Agilent Description, Business Overview
5.2.3 Agilent Oligonucleotides Products Offered
5.2.4 Agilent Oligonucleotides Revenue and Gross Margin (2020-2025)
5.2.5 Agilent Oligonucleotides Revenue by Product in 2024
5.2.6 Agilent Oligonucleotides Revenue by Application in 2024
5.2.7 Agilent Oligonucleotides Revenue by Geographic Area in 2024
5.2.8 Agilent Recent Developments
5.3 Sigma-aldrich
5.3.1 Sigma-aldrich Corporation Information
5.3.2 Sigma-aldrich Description, Business Overview
5.3.3 Sigma-aldrich Oligonucleotides Products Offered
5.3.4 Sigma-aldrich Oligonucleotides Revenue and Gross Margin (2020-2025)
5.3.5 Sigma-aldrich Oligonucleotides Revenue by Product in 2024
5.3.6 Sigma-aldrich Oligonucleotides Revenue by Application in 2024
5.3.7 Sigma-aldrich Oligonucleotides Revenue by Geographic Area in 2024
5.3.8 Sigma-aldrich Recent Developments
5.4 Eurofins Genomics
5.4.1 Eurofins Genomics Corporation Information
5.4.2 Eurofins Genomics Description, Business Overview
5.4.3 Eurofins Genomics Oligonucleotides Products Offered
5.4.4 Eurofins Genomics Oligonucleotides Revenue and Gross Margin (2020-2025)
5.4.5 Eurofins Genomics Oligonucleotides Revenue by Product in 2024
5.4.6 Eurofins Genomics Oligonucleotides Revenue by Application in 2024
5.4.7 Eurofins Genomics Oligonucleotides Revenue by Geographic Area in 2024
5.4.8 Eurofins Genomics Recent Developments
5.5 L.G.C Biosearch Technologies
5.5.1 L.G.C Biosearch Technologies Corporation Information
5.5.2 L.G.C Biosearch Technologies Description, Business Overview
5.5.3 L.G.C Biosearch Technologies Oligonucleotides Products Offered
5.5.4 L.G.C Biosearch Technologies Oligonucleotides Revenue and Gross Margin (2020-2025)
5.5.5 L.G.C Biosearch Technologies Oligonucleotides Revenue by Product in 2024
5.5.6 L.G.C Biosearch Technologies Oligonucleotides Revenue by Application in 2024
5.5.7 L.G.C Biosearch Technologies Oligonucleotides Revenue by Geographic Area in 2024
5.5.8 L.G.C Biosearch Technologies Recent Developments
5.6 Eurogentec S.A
5.6.1 Eurogentec S.A Corporation Information
5.6.2 Eurogentec S.A Description, Business Overview
5.6.3 Eurogentec S.A Oligonucleotides Products Offered
5.6.4 Eurogentec S.A Oligonucleotides Revenue and Gross Margin (2020-2025)
5.6.5 Eurogentec S.A Oligonucleotides Revenue by Product in 2024
5.6.6 Eurogentec S.A Oligonucleotides Revenue by Application in 2024
5.6.7 Eurogentec S.A Oligonucleotides Revenue by Geographic Area in 2024
5.6.8 Eurogentec S.A Recent Developments
5.7 Nitto Denko Avecia Inc
5.7.1 Nitto Denko Avecia Inc Corporation Information
5.7.2 Nitto Denko Avecia Inc Description, Business Overview
5.7.3 Nitto Denko Avecia Inc Oligonucleotides Products Offered
5.7.4 Nitto Denko Avecia Inc Oligonucleotides Revenue and Gross Margin (2020-2025)
5.7.5 Nitto Denko Avecia Inc Oligonucleotides Revenue by Product in 2024
5.7.6 Nitto Denko Avecia Inc Oligonucleotides Revenue by Application in 2024
5.7.7 Nitto Denko Avecia Inc Oligonucleotides Revenue by Geographic Area in 2024
5.7.8 Nitto Denko Avecia Inc Recent Developments
5.8 GenScript
5.8.1 GenScript Corporation Information
5.8.2 GenScript Description, Business Overview
5.8.3 GenScript Oligonucleotides Products Offered
5.8.4 GenScript Oligonucleotides Revenue and Gross Margin (2020-2025)
5.8.5 GenScript Oligonucleotides Revenue by Product in 2024
5.8.6 GenScript Oligonucleotides Revenue by Application in 2024
5.8.7 GenScript Oligonucleotides Revenue by Geographic Area in 2024
5.8.8 GenScript Recent Developments
5.9 BBI Life Sciences
5.9.1 BBI Life Sciences Corporation Information
5.9.2 BBI Life Sciences Description, Business Overview
5.9.3 BBI Life Sciences Oligonucleotides Products Offered
5.9.4 BBI Life Sciences Oligonucleotides Revenue and Gross Margin (2020-2025)
5.9.5 BBI Life Sciences Oligonucleotides Revenue by Product in 2024
5.9.6 BBI Life Sciences Oligonucleotides Revenue by Application in 2024
5.9.7 BBI Life Sciences Oligonucleotides Revenue by Geographic Area in 2024
5.9.8 BBI Life Sciences Recent Developments
5.10 GeneDesign
5.10.1 GeneDesign Corporation Information
5.10.2 GeneDesign Description, Business Overview
5.10.3 GeneDesign Oligonucleotides Products Offered
5.10.4 GeneDesign Oligonucleotides Revenue and Gross Margin (2020-2025)
5.10.5 GeneDesign Oligonucleotides Revenue by Product in 2024
5.10.6 GeneDesign Oligonucleotides Revenue by Application in 2024
5.10.7 GeneDesign Oligonucleotides Revenue by Geographic Area in 2024
5.10.8 GeneDesign Recent Developments
5.11 TriLink BioTechnologies
5.11.1 TriLink BioTechnologies Corporation Information
5.11.2 TriLink BioTechnologies Description, Business Overview
5.11.3 TriLink BioTechnologies Oligonucleotides Products Offered
5.11.4 TriLink BioTechnologies Oligonucleotides Revenue and Gross Margin (2020-2025)
5.11.5 TriLink BioTechnologies Oligonucleotides Revenue by Product in 2024
5.11.6 TriLink BioTechnologies Oligonucleotides Revenue by Application in 2024
5.11.7 TriLink BioTechnologies Oligonucleotides Revenue by Geographic Area in 2024
5.11.8 TriLink BioTechnologies Recent Developments
5.12 SGS DNA
5.12.1 SGS DNA Corporation Information
5.12.2 SGS DNA Description, Business Overview
5.12.3 SGS DNA Oligonucleotides Products Offered
5.12.4 SGS DNA Oligonucleotides Revenue and Gross Margin (2020-2025)
5.12.5 SGS DNA Oligonucleotides Revenue by Product in 2024
5.12.6 SGS DNA Oligonucleotides Revenue by Application in 2024
5.12.7 SGS DNA Oligonucleotides Revenue by Geographic Area in 2024
5.12.8 SGS DNA Recent Developments
5.13 LC Sciences
5.13.1 LC Sciences Corporation Information
5.13.2 LC Sciences Description, Business Overview
5.13.3 LC Sciences Oligonucleotides Products Offered
5.13.4 LC Sciences Oligonucleotides Revenue and Gross Margin (2020-2025)
5.13.5 LC Sciences Oligonucleotides Revenue by Product in 2024
5.13.6 LC Sciences Oligonucleotides Revenue by Application in 2024
5.13.7 LC Sciences Oligonucleotides Revenue by Geographic Area in 2024
5.13.8 LC Sciences Recent Developments
5.14 Twist Bioscience
5.14.1 Twist Bioscience Corporation Information
5.14.2 Twist Bioscience Description, Business Overview
5.14.3 Twist Bioscience Oligonucleotides Products Offered
5.14.4 Twist Bioscience Oligonucleotides Revenue and Gross Margin (2020-2025)
5.14.5 Twist Bioscience Oligonucleotides Revenue by Product in 2024
5.14.6 Twist Bioscience Oligonucleotides Revenue by Application in 2024
5.14.7 Twist Bioscience Oligonucleotides Revenue by Geographic Area in 2024
5.14.8 Twist Bioscience Recent Developments
5.15 Creative Biogene
5.15.1 Creative Biogene Corporation Information
5.15.2 Creative Biogene Description, Business Overview
5.15.3 Creative Biogene Oligonucleotides Products Offered
5.15.4 Creative Biogene Oligonucleotides Revenue and Gross Margin (2020-2025)
5.15.5 Creative Biogene Oligonucleotides Revenue by Product in 2024
5.15.6 Creative Biogene Oligonucleotides Revenue by Application in 2024
5.15.7 Creative Biogene Oligonucleotides Revenue by Geographic Area in 2024
5.15.8 Creative Biogene Recent Developments
5.16 General Biosystems
5.16.1 General Biosystems Corporation Information
5.16.2 General Biosystems Description, Business Overview
5.16.3 General Biosystems Oligonucleotides Products Offered
5.16.4 General Biosystems Oligonucleotides Revenue and Gross Margin (2020-2025)
5.16.5 General Biosystems Oligonucleotides Revenue by Product in 2024
5.16.6 General Biosystems Oligonucleotides Revenue by Application in 2024
5.16.7 General Biosystems Oligonucleotides Revenue by Geographic Area in 2024
5.16.8 General Biosystems Recent Developments
6 North America
6.1 North America Oligonucleotides Market Size YoY Growth 2020-2031
6.2 North America Oligonucleotides Market Facts & Figures by Country (2020-2031)
6.3 North America Oligonucleotides Revenue by Type (2020-2025)
6.4 North America Oligonucleotides Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Oligonucleotides Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Oligonucleotides Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Oligonucleotides Revenue by Type (2020-2025)
7.4 Asia-Pacific Oligonucleotides Revenue by Application (2020-2025)
8 Europe
8.1 Europe Oligonucleotides Market Size YoY Growth 2020-2031
8.2 Europe Oligonucleotides Market Facts & Figures by Country (2020-2031)
8.3 Europe Oligonucleotides Revenue by Type (2020-2025)
8.4 Europe Oligonucleotides Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Oligonucleotides Market Size YoY Growth 2020-2031
9.2 Latin America Oligonucleotides Market Facts & Figures by Country (2020-2031)
9.3 Latin America Oligonucleotides Revenue by Type (2020-2025)
9.4 Latin America Oligonucleotides Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Oligonucleotides Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Oligonucleotides Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Oligonucleotides Revenue by Type (2020-2025)
10.4 Middle East and Africa Oligonucleotides Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Oligonucleotides Supply Chain Analysis
11.2 Oligonucleotides Key Raw Materials and Upstream Suppliers
11.3 Oligonucleotides Clients Analysis
11.4 Oligonucleotides Sales Channel and Sales Model Analysis
11.4.1 Oligonucleotides Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Oligonucleotides Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Oligonucleotides Distributors
12 Oligonucleotides Market Dynamics
12.1 Oligonucleotides Industry Trends
12.2 Oligonucleotides Market Drivers
12.3 Oligonucleotides Market Challenges
12.4 Oligonucleotides Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
List of Tables
 Table 1. Global Oligonucleotides Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Oligonucleotides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Oligonucleotides Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Oligonucleotides Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Oligonucleotides Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Oligonucleotides Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Oligonucleotides Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Oligonucleotides Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Oligonucleotides Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Oligonucleotides Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Oligonucleotides Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Oligonucleotides Players by Revenue (US$ Million) in 2024
 Table 13. Global Oligonucleotides Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotides as of 2024)
 Table 15. Global Oligonucleotides Companies Headquarters
 Table 16. Date of International Companies Enter into Oligonucleotides Market
 Table 17. Global Oligonucleotides Companies Product & Service
 Table 18. Global Oligonucleotides Mergers & Acquisitions, Expansion Plans
 Table 19. Integrated DNA Technologies Corporation Information
 Table 20. Integrated DNA Technologies Description and Business Overview
 Table 21. Integrated DNA Technologies Oligonucleotides Product
 Table 22. Integrated DNA Technologies Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Integrated DNA Technologies Revenue Proportion of Oligonucleotides by Product in 2024
 Table 24. Integrated DNA Technologies Revenue Proportion of Oligonucleotides by Application in 2024
 Table 25. Integrated DNA Technologies Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 26. Integrated DNA Technologies Recent Developments
 Table 27. Agilent Corporation Information
 Table 28. Agilent Description and Business Overview
 Table 29. Agilent Oligonucleotides Product
 Table 30. Agilent Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Agilent Revenue Proportion of Oligonucleotides by Product in 2024
 Table 32. Agilent Revenue Proportion of Oligonucleotides by Application in 2024
 Table 33. Agilent Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 34. Agilent Recent Developments
 Table 35. Sigma-aldrich Corporation Information
 Table 36. Sigma-aldrich Description and Business Overview
 Table 37. Sigma-aldrich Oligonucleotides Product
 Table 38. Sigma-aldrich Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Sigma-aldrich Revenue Proportion of Oligonucleotides by Product in 2024
 Table 40. Sigma-aldrich Revenue Proportion of Oligonucleotides by Application in 2024
 Table 41. Sigma-aldrich Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 42. Sigma-aldrich Recent Developments
 Table 43. Eurofins Genomics Corporation Information
 Table 44. Eurofins Genomics Description and Business Overview
 Table 45. Eurofins Genomics Oligonucleotides Product
 Table 46. Eurofins Genomics Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Eurofins Genomics Revenue Proportion of Oligonucleotides by Product in 2024
 Table 48. Eurofins Genomics Revenue Proportion of Oligonucleotides by Application in 2024
 Table 49. Eurofins Genomics Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 50. Eurofins Genomics Recent Developments
 Table 51. L.G.C Biosearch Technologies Corporation Information
 Table 52. L.G.C Biosearch Technologies Description and Business Overview
 Table 53. L.G.C Biosearch Technologies Oligonucleotides Product
 Table 54. L.G.C Biosearch Technologies Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. L.G.C Biosearch Technologies Revenue Proportion of Oligonucleotides by Product in 2024
 Table 56. L.G.C Biosearch Technologies Revenue Proportion of Oligonucleotides by Application in 2024
 Table 57. L.G.C Biosearch Technologies Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 58. L.G.C Biosearch Technologies Recent Developments
 Table 59. Eurogentec S.A Corporation Information
 Table 60. Eurogentec S.A Description and Business Overview
 Table 61. Eurogentec S.A Oligonucleotides Product
 Table 62. Eurogentec S.A Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Eurogentec S.A Revenue Proportion of Oligonucleotides by Product in 2024
 Table 64. Eurogentec S.A Revenue Proportion of Oligonucleotides by Application in 2024
 Table 65. Eurogentec S.A Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 66. Eurogentec S.A Recent Developments
 Table 67. Nitto Denko Avecia Inc Corporation Information
 Table 68. Nitto Denko Avecia Inc Description and Business Overview
 Table 69. Nitto Denko Avecia Inc Oligonucleotides Product
 Table 70. Nitto Denko Avecia Inc Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Nitto Denko Avecia Inc Revenue Proportion of Oligonucleotides by Product in 2024
 Table 72. Nitto Denko Avecia Inc Revenue Proportion of Oligonucleotides by Application in 2024
 Table 73. Nitto Denko Avecia Inc Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 74. Nitto Denko Avecia Inc Recent Developments
 Table 75. GenScript Corporation Information
 Table 76. GenScript Description and Business Overview
 Table 77. GenScript Oligonucleotides Product
 Table 78. GenScript Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. GenScript Revenue Proportion of Oligonucleotides by Product in 2024
 Table 80. GenScript Revenue Proportion of Oligonucleotides by Application in 2024
 Table 81. GenScript Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 82. GenScript Recent Developments
 Table 83. BBI Life Sciences Corporation Information
 Table 84. BBI Life Sciences Description and Business Overview
 Table 85. BBI Life Sciences Oligonucleotides Product
 Table 86. BBI Life Sciences Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. BBI Life Sciences Revenue Proportion of Oligonucleotides by Product in 2024
 Table 88. BBI Life Sciences Revenue Proportion of Oligonucleotides by Application in 2024
 Table 89. BBI Life Sciences Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 90. BBI Life Sciences Recent Developments
 Table 91. GeneDesign Corporation Information
 Table 92. GeneDesign Description and Business Overview
 Table 93. GeneDesign Oligonucleotides Product
 Table 94. GeneDesign Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. GeneDesign Revenue Proportion of Oligonucleotides by Product in 2024
 Table 96. GeneDesign Revenue Proportion of Oligonucleotides by Application in 2024
 Table 97. GeneDesign Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 98. GeneDesign Recent Developments
 Table 99. TriLink BioTechnologies Corporation Information
 Table 100. TriLink BioTechnologies Description and Business Overview
 Table 101. TriLink BioTechnologies Oligonucleotides Product
 Table 102. TriLink BioTechnologies Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. TriLink BioTechnologies Revenue Proportion of Oligonucleotides by Product in 2024
 Table 104. TriLink BioTechnologies Revenue Proportion of Oligonucleotides by Application in 2024
 Table 105. TriLink BioTechnologies Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 106. TriLink BioTechnologies Recent Developments
 Table 107. SGS DNA Corporation Information
 Table 108. SGS DNA Description and Business Overview
 Table 109. SGS DNA Oligonucleotides Product
 Table 110. SGS DNA Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. SGS DNA Revenue Proportion of Oligonucleotides by Product in 2024
 Table 112. SGS DNA Revenue Proportion of Oligonucleotides by Application in 2024
 Table 113. SGS DNA Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 114. SGS DNA Recent Developments
 Table 115. LC Sciences Corporation Information
 Table 116. LC Sciences Description and Business Overview
 Table 117. LC Sciences Oligonucleotides Product
 Table 118. LC Sciences Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. LC Sciences Revenue Proportion of Oligonucleotides by Product in 2024
 Table 120. LC Sciences Revenue Proportion of Oligonucleotides by Application in 2024
 Table 121. LC Sciences Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 122. LC Sciences Recent Developments
 Table 123. Twist Bioscience Corporation Information
 Table 124. Twist Bioscience Description and Business Overview
 Table 125. Twist Bioscience Oligonucleotides Product
 Table 126. Twist Bioscience Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. Twist Bioscience Revenue Proportion of Oligonucleotides by Product in 2024
 Table 128. Twist Bioscience Revenue Proportion of Oligonucleotides by Application in 2024
 Table 129. Twist Bioscience Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 130. Twist Bioscience Recent Developments
 Table 131. Creative Biogene Corporation Information
 Table 132. Creative Biogene Description and Business Overview
 Table 133. Creative Biogene Oligonucleotides Product
 Table 134. Creative Biogene Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 135. Creative Biogene Revenue Proportion of Oligonucleotides by Product in 2024
 Table 136. Creative Biogene Revenue Proportion of Oligonucleotides by Application in 2024
 Table 137. Creative Biogene Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 138. Creative Biogene Recent Developments
 Table 139. General Biosystems Corporation Information
 Table 140. General Biosystems Description and Business Overview
 Table 141. General Biosystems Oligonucleotides Product
 Table 142. General Biosystems Oligonucleotides Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. General Biosystems Revenue Proportion of Oligonucleotides by Product in 2024
 Table 144. General Biosystems Revenue Proportion of Oligonucleotides by Application in 2024
 Table 145. General Biosystems Revenue Proportion of Oligonucleotides by Geographic Area in 2024
 Table 146. General Biosystems Recent Developments
 Table 147. North America Oligonucleotides Revenue by Country (2020-2025) & (US$ Million)
 Table 148. North America Oligonucleotides Revenue by Country (2026-2031) & (US$ Million)
 Table 149. North America Oligonucleotides Revenue by Type (2020-2025) & (US$ Million)
 Table 150. North America Oligonucleotides Revenue by Application (2020-2025) & (US$ Million)
 Table 151. Asia-Pacific Oligonucleotides Revenue by Region (2020-2025) & (US$ Million)
 Table 152. Asia-Pacific Oligonucleotides Revenue by Region (2026-2031) & (US$ Million)
 Table 153. Asia-Pacific Oligonucleotides Revenue by Type (2020-2025) & (US$ Million)
 Table 154. Asia-Pacific Oligonucleotides Revenue by Application (2020-2025) & (US$ Million)
 Table 155. Europe Oligonucleotides Revenue by Country (2020-2025) & (US$ Million)
 Table 156. Europe Oligonucleotides Revenue by Country (2026-2031) & (US$ Million)
 Table 157. Europe Oligonucleotides Revenue by Type (2020-2025) & (US$ Million)
 Table 158. Europe Oligonucleotides Revenue by Application (2020-2025) & (US$ Million)
 Table 159. Latin America Oligonucleotides Revenue by Country (2020-2025) & (US$ Million)
 Table 160. Latin America Oligonucleotides Revenue by Country (2026-2031) & (US$ Million)
 Table 161. Latin America Oligonucleotides Revenue by Type (2020-2025) & (US$ Million)
 Table 162. Latin America Oligonucleotides Revenue by Application (2020-2025) & (US$ Million)
 Table 163. Middle East and Africa Oligonucleotides Revenue by Country (2020-2025) & (US$ Million)
 Table 164. Middle East and Africa Oligonucleotides Revenue by Country (2026-2031) & (US$ Million)
 Table 165. Middle East and Africa Oligonucleotides Revenue by Type (2020-2025) & (US$ Million)
 Table 166. Middle East and Africa Oligonucleotides Revenue by Application (2020-2025) & (US$ Million)
 Table 167. Oligonucleotides Key Raw Materials, Industry Status and Trend
 Table 168. Oligonucleotides Key Raw Materials and Upstream Suppliers
 Table 169. Oligonucleotides Clients Status and Trend
 Table 170. Oligonucleotides Typical Clients
 Table 171. Oligonucleotides Distributors
 Table 172. Oligonucleotides Market Trends
 Table 173. Oligonucleotides Market Drivers
 Table 174. Oligonucleotides Market Challenges
 Table 175. Oligonucleotides Market Restraints
 Table 176. Research Programs/Design for This Report
 Table 177. Key Data Information from Secondary Sources
 Table 178. Key Data Information from Primary Sources


List of Figures
 Figure 1. Oligonucleotides Product Picture
 Figure 2. Global Oligonucleotides Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Oligonucleotides Revenue Market Share by Type in 2024 & 2031
 Figure 4. DNA Oligos Product Picture
 Figure 5. RNA Oligos Product Picture
 Figure 6. Global Oligonucleotides Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Oligonucleotides Revenue Market Share by Application in 2024 & 2031
 Figure 8. Pharmaceutical
 Figure 9. Research
 Figure 10. Diagnostic
 Figure 11. Oligonucleotides Report Years Considered
 Figure 12. Global Oligonucleotides Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Oligonucleotides Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Oligonucleotides Market Size Market Share by Region: 2024 Versus 2031
 Figure 15. Global Oligonucleotides Revenue Market Share by Region (2020-2031)
 Figure 16. Global Oligonucleotides Revenue Market Share Forecast by Type (2020-2031)
 Figure 17. Global Oligonucleotides Revenue Market Share Forecast by Application (2020-2031)
 Figure 18. DNA Oligos of Oligonucleotides Revenue Market Share by Application, 2024 VS 2031
 Figure 19. RNA Oligos of Oligonucleotides Revenue Market Share by Application, 2024 VS 2031
 Figure 20. Oligonucleotides Revenue Share by Company (2024)
 Figure 21. Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. DNA Oligos Revenue Proportion by Company in 2024
 Figure 23. RNA Oligos Revenue Proportion by Company in 2024
 Figure 24. North America Oligonucleotides Revenue 2020-2031 (US$ Million)
 Figure 25. North America Oligonucleotides Revenue Market Share by Type (2020-2025)
 Figure 26. North America Oligonucleotides Revenue Market Share by Application (2020-2025)
 Figure 27. Asia-Pacific Oligonucleotides Revenue 2020-2031 (US$ Million)
 Figure 28. Asia-Pacific Oligonucleotides Revenue Market Share by Region (2020-2031)
 Figure 29. Asia-Pacific Oligonucleotides Revenue Market Share by Type (2020-2025)
 Figure 30. Asia-Pacific Oligonucleotides Revenue Market Share by Application (2020-2025)
 Figure 31. Europe Oligonucleotides Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 32. Europe Oligonucleotides Revenue Market Share by Country (2020-2031)
 Figure 33. Europe Oligonucleotides Revenue Market Share by Type (2020-2025)
 Figure 34. Europe Oligonucleotides Revenue Market Share by Application (2020-2025)
 Figure 35. Latin America Oligonucleotides Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 36. Latin America Oligonucleotides Revenue Market Share by Country (2020-2031)
 Figure 37. Latin America Oligonucleotides Revenue Market Share by Type (2020-2025)
 Figure 38. Latin America Oligonucleotides Revenue Market Share by Application (2020-2025)
 Figure 39. Middle East and Africa Oligonucleotides Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 40. Middle East and Africa Oligonucleotides Revenue Market Share by Country (2020-2031)
 Figure 41. Middle East and Africa Oligonucleotides Revenue Market Share by Type (2020-2025)
 Figure 42. Middle East and Africa Oligonucleotides Revenue Market Share by Application (2020-2025)
 Figure 43. Oligonucleotides Supply Chain (Upstream and Downstream Market)
 Figure 44. Global Production Market Share of Oligonucleotides Raw Materials by Region in 2024
 Figure 45. Oligonucleotides Distribution Channels
 Figure 46. Global Oligonucleotides Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 47. Global Oligonucleotides Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 48. Bottom-up and Top-down Approaches for This Report
 Figure 49. Data Triangulation
 Figure 50. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

DNA RNA Oligonucleotides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oligonucleotide Market Research Report 2025
Global Oligo Synthesis Market Research Report 2025
Global Oligonucleotide Solid Phase Synthesizer Market Research Report 2024
Oligonucleotide Synthesis Linkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DNA Oligonucleotide Synthesis Market Insights Forecast to 2030
Global Oligonucleotide Synthesizer Market Research Report 2024
Global Oligonucleotide Synthesis Services Market Insights Forecast to 2030
Global Oligonucleotide Oligo Drugs Market Research Report 2024
Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oligo Synthesizer Market Insights Forecast to 2030
Global Oligonucleotide Drug Carriers Market Research Report 2024
Global Oligonucleotide Therapeutics Market Research Report 2024
Global DNA and RNA Oligonucleotide Synthesizers Market Research Report 2024
Global Phosphoramidites for Oligonucleotides Market Research Report 2024
Global Automated Oligonucleotide Synthesizer Market Research Report 2024
Global Solid phase Oligonucleotide Synthesis Market Research Report 2025
DNA And RNA Synthesis Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oligonucleotide Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oligonucleotide Drugs ONs Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions